These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8079794)

  • 21. Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure.
    Hartog A; Gommers D; Haitsma JJ; Lachmann B
    Br J Anaesth; 2000 Nov; 85(5):752-6. PubMed ID: 11094593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of surfactant replacement on respiratory failure induced by free oxygen radicals.
    Lachmann B; Saugstad OD; Erdmann W
    Prog Clin Biol Res; 1987; 236B():305-13. PubMed ID: 3615475
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease.
    Klein MI; Coviello S; Bauer G; Benitez A; Serra ME; Schiatti MP; Delgado MF; Melendi GA; Novalli L; Pena HG; Karron RA; Kleeberger SR; Polack FP
    J Infect Dis; 2006 Jun; 193(11):1544-51. PubMed ID: 16652283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered histopathology in protein-deprived mice during Sendai virus pneumonia: evidence for delayed inflammatory response and recovery.
    Peña-Cruz V; Bronson RT; Reiss CS; McIntosh K
    J Infect Dis; 1992 May; 165(5):846-51. PubMed ID: 1314870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in lung mechanics and histamine responsiveness after sequential canine adenovirus 2 and canine parainfluenza 2 virus infection in beagle puppies.
    Quan SF; Witten ML; Grad R; Ray CG; Lemen RJ
    Pediatr Pulmonol; 1991; 10(4):236-43. PubMed ID: 1654540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute pneumonia in influenza and other respiratory viral diseases].
    Ketiladze ES
    Ter Arkh; 1975; 47(8):39-49. PubMed ID: 171787
    [No Abstract]   [Full Text] [Related]  

  • 27. Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.
    Putz G; Hörmann C; Koller W; Schön G
    Intensive Care Med; 1996 Jun; 22(6):588-90. PubMed ID: 8814477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats.
    Tashiro K; Yamada K; Konzaki T; Yamamoto K; Ohmura S; Kobayashi T; Suzuki Y
    Br J Anaesth; 2001 Aug; 87(2):266-71. PubMed ID: 11493500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in the exogenous pulmonary surfactant replacement therapy for the adult respiratory distress syndrome].
    Xie E; Yang Z
    Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):183-5. PubMed ID: 7780826
    [No Abstract]   [Full Text] [Related]  

  • 30. Adult respiratory distress syndrome.
    Gracey DR
    Heart Lung; 1975; 4(2):280-3. PubMed ID: 1039982
    [No Abstract]   [Full Text] [Related]  

  • 31. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant therapy and intravenous zanamivir in severe respiratory failure due to persistent influenza A/H1N1 2009 virus infection.
    Busani S; Girardis M; Biagioni E; Pasetto A; Sambri V
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1334. PubMed ID: 21079271
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of 4-ipomeanol on bovine parainfluenza type 3 virus-induced pneumonia in calves.
    Li X; Castleman WL
    Vet Pathol; 1991 Sep; 28(5):428-37. PubMed ID: 1661042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
    Häfner D; Germann PG; Hauschke D
    Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bronchitis and the pneumonic syndrome. 32. Pathological anatomy of the pneumonic syndrome].
    Güthert H
    Z Gesamte Inn Med; 1967 Apr; 22(7):Suppl:110-2. PubMed ID: 4300282
    [No Abstract]   [Full Text] [Related]  

  • 37. Impairment of deep lung clearance by influenza virus infection.
    Creasia DA; Nettesheim P; Hammons AS
    Arch Environ Health; 1973 Apr; 26(4):197-201. PubMed ID: 4689796
    [No Abstract]   [Full Text] [Related]  

  • 38. [The pulmonary surfactant system and respiratory mechanics in patients with acute postoperative respiratory failure].
    Mustafin AKh; Egoshin VL; Kakenova TI; Makanova RS
    Anesteziol Reanimatol; 1990; (1):50-1. PubMed ID: 2350048
    [No Abstract]   [Full Text] [Related]  

  • 39. The Role of Surfactant Therapy in Nonrespiratory Distress Syndrome Conditions in Neonates.
    Keiser A; Bhandari V
    Am J Perinatol; 2016 Jan; 33(1):1-8. PubMed ID: 26171600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation in a model of acute lung injury.
    Hartog A; Vazquez de Anda GF; Gommers D; Kaisers U; Verbrugge SJ; Schnabel R; Lachmann B
    Br J Anaesth; 1999 Jan; 82(1):81-6. PubMed ID: 10325841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.